Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.

Abstract excerpt

The RAS proteins play a role in cell differentiation, proliferation, and survival. Aberrant RAS signaling has been found to play a role in 30% of all cancers. KRAS, a key member of the RAS protein family, is an attractive cancer target, as frequent point mutations in the KRAS gene render the protein constitutively active. A number of attempts have been made to target aberrant KRAS signaling by identifying small...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Cycle Proteins
• Share to Molecular Structure
• Share to Molecular Targeted Therapy